Arcus Biosciences Inc -Well-Positioned to Advance Full Pipeline With $1.1 Bln in Cash, Cash Equivalents and Marketable Securities and Runway Into 2027
Arcus Biosciences Inc-完全有能力將11億美元的現金、現金等價物和有價證券的全部管道推進到2027年
Arcus Biosciences Inc -Well-Positioned to Advance Full Pipeline With $1.1 Bln in Cash, Cash Equivalents and Marketable Securities and Runway Into 2027
Arcus Biosciences Inc-完全有能力將11億美元的現金、現金等價物和有價證券的全部管道推進到2027年
使用瀏覽器的分享功能,分享給你的好友吧